BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8194324)

  • 1. Use of a hemoglobin substitute in the anemic Jehovah's Witness patient.
    Marelli TR
    Crit Care Nurse; 1994 Feb; 14(1):31-8. PubMed ID: 8194324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluosol-DA as a red-cell substitute in acute anemia.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Langdale LA; Krause LM; Rice CL; Chamberlin WH; Moss GS
    N Engl J Med; 1986 Jun; 314(26):1653-6. PubMed ID: 3713771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a whole blood substitute, Fluosol-DA 20%, after massive postpartum hemorrhage.
    Karn KE; Ogburn PL; Julian T; Cerra FB; Hammerschmidt DE; Vercellotti G
    Obstet Gynecol; 1985 Jan; 65(1):127-30. PubMed ID: 3871250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of anaemia in the polytrauma Jehovah's Witness.
    Murphy DP; O'Donnell T; McDonnell J; McElwain JP
    Ir Med J; 2003 Jan; 96(1):8-10. PubMed ID: 12617434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is hemoglobin level alone a reliable predictor of outcome in the severely anemic surgical patient?
    Spence RK; Costabile JP; Young GS; Norcross ED; Alexander JB; Pello MJ; Atabek UM; Camishion RC
    Am Surg; 1992 Feb; 58(2):92-5. PubMed ID: 1550312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of acute anemia in a Jehovah's Witness patient with acute lymphoblastic leukemia with polymerized bovine hemoglobin-based oxygen carrier: a case report and review of literature.
    Donahue LL; Shapira I; Shander A; Kolitz J; Allen S; Greenburg G
    Transfusion; 2010 Jul; 50(7):1561-7. PubMed ID: 20456679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluosol: therapeutic failure in severe anemia.
    Kale PB; Sklar GE; Wesolowicz LA; DiLisio RE
    Ann Pharmacother; 1993 Dec; 27(12):1452-4. PubMed ID: 8305774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jehovah's Witnesses: unique problems in a unique trauma population.
    Victorino G; Wisner DH
    J Am Coll Surg; 1997 May; 184(5):458-68. PubMed ID: 9145065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe anemia in the Jehovah's Witness: case report and discussion.
    Collins SL; Timberlake GA
    Am J Crit Care; 1993 May; 2(3):256-9. PubMed ID: 8364678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a blood substitute in a patient who refuses to accept a transfusion.
    Frackiewicz EJ; Lee R
    Am J Hosp Pharm; 1991 Oct; 48(10):2176; discussion 2176-80. PubMed ID: 1781475
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluosol DA-20 in the treatment of severe anemia: randomized, controlled study of 46 patients.
    Spence RK; McCoy S; Costabile J; Norcross ED; Pello MJ; Alexander JB; Wisdom C; Camishion RC
    Crit Care Med; 1990 Nov; 18(11):1227-30. PubMed ID: 1699704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in general and vascular surgical care of Jehovah's Witnesses.
    Majeski J
    Int Surg; 2000; 85(3):257-65. PubMed ID: 11325007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA.
    Tremper KK; Friedman AE; Levine EM; Lapin R; Camarillo D
    N Engl J Med; 1982 Jul; 307(5):277-83. PubMed ID: 7045667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating severe anemia in a trauma patient who is a Jehovah's witness.
    Gilcreast DM; Avella P; Camarillo E; Mullane G
    Crit Care Nurse; 2001 Apr; 21(2):69-72, 75-8, 80-2. PubMed ID: 11858442
    [No Abstract]   [Full Text] [Related]  

  • 15. Perfluorocarbons as blood substitutes: the early years. Experience with Fluosol DA-20% in the 1980s.
    Spence RK; Norcross ED; Costabile J; McCoy S; Cernaianu AC; Alexander JB; Pello MJ; Atabek U; Camishion RC
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):955-63. PubMed ID: 7849967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluosol-DA, a perfluorochemical oxygen-transport fluid for the management of a trochanteric pressure sore in a Jehovah's Witness.
    Brown AS; Reichman JH; Spence RK
    Ann Plast Surg; 1984 May; 12(5):449-53. PubMed ID: 6742725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Care of the injured Jehovah's Witness patient: case report and review of the literature.
    Kulvatunyou N; Heard SO
    J Clin Anesth; 2004 Nov; 16(7):548-53. PubMed ID: 15590263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of hemoglobin raffimer for postoperative life-threatening anemia in a Jehovah's Witness.
    Lanzinger MJ; Niklason LE; Shannon M; Hill SE
    Can J Anaesth; 2005 Apr; 52(4):369-73. PubMed ID: 15814750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Survival of very severe hemorrhage-induced anemia in a Jehovah's Witness].
    Tessmann R; von Lüpke U
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Oct; 31(8):501-4. PubMed ID: 9019184
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluosol-DA as a red-cell substitute in acute anemia.
    N Engl J Med; 1986 Dec; 315(26):1677-8. PubMed ID: 3785341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.